CERK Antikörper
-
- Target Alle CERK Antikörper anzeigen
- CERK (Ceramide Kinase (CERK))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CERK Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human CERK
- Isotyp
- IgG
- Top Product
- Discover our top product CERK Primärantikörper
-
anti-Ceramide Kinase (CERK) (AA 212-478) antibody
CERK Reaktivität: Human ELISA, WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Ceramide Kinase (CERK) (AA 487-516), (C-Term) antibodyCERK Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB5271 unconjugated
anti-Ceramide Kinase (CERK) (C-Term) antibodyCERK Reaktivität: Human, Maus ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Ceramide Kinase (CERK) (AA 1-201) antibodyCERK Reaktivität: Human ELISA, WB Wirt: Maus Polyclonal unconjugated
anti-Ceramide Kinase (CERK) (AA 50-150) antibodyCERK Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Ceramide Kinase (CERK) (AA 487-516) antibodyCERK Reaktivität: Human, Maus WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Ceramide Kinase (CERK) (AA 1-201) antibodyCERK Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Ceramide Kinase (CERK) (C-Term) antibodyCERK Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Ceramide Kinase (CERK) antibodyCERK Reaktivität: Human, Affe IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:25-1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.3 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CERK (Ceramide Kinase (CERK))
- Andere Bezeichnung
- CERK (CERK Produkte)
- Synonyme
- AI848610 antikoerper, D330016D08Rik antikoerper, mKIAA1646 antikoerper, LK4 antikoerper, dA59H18.2 antikoerper, dA59H18.3 antikoerper, hCERK antikoerper, CERK antikoerper, si:ch211-162i19.1 antikoerper, MGC81777 antikoerper, CG16708 antikoerper, DCERK antikoerper, Dcerk antikoerper, Dmel\\CG16708 antikoerper, dcerk antikoerper, ceramide kinase antikoerper, ceramide kinase S homeolog antikoerper, Ceramide kinase antikoerper, Cerk antikoerper, CERK antikoerper, cerk antikoerper, cerk.S antikoerper, CpipJ_CPIJ003342 antikoerper, LOAG_11245 antikoerper, LOC5579301 antikoerper, Bm1_50005 antikoerper
- Hintergrund
- CERK converts ceramide to ceramide 1-phosphate (C1P), a sphingolipid metabolite. Both CERK and C1P have been implicated in various cellular processes, including proliferation, apoptosis, phagocytosis, and inflammation. Catalyzes specifically the phosphorylation of ceramide to form ceramide 1-phosphate. Acts efficiently on natural and analog ceramides (C6, C8, C16 ceramides, and C8-dihydroceramide), to a lesser extent on C2-ceramide and C6-dihydroceramide, but not on other lipids, such as various sphingosines. Binds phosphoinositides.
- UniProt
- Q8TCT0
-
